fibrosis

Skye and Redx combine with $125M to advance fibrosis assets

Skye Bioscience and Redx Pharma have combined in a deal that will net $125 million in financing for the new public company, called Fibrx Therapeutics.

Will Maddox Aug 14, 2026 2:05pm

ChatGPT said Low-poly magenta liver model centered on a pale blue background patterned with sketchy dollar signs suggestin

Fierce Pharma

Big Pharma bets big on MASH with a new combo playbook

Oct 17, 2025 9:30am

Roche launches liver fibrosis blood test for MASLD

May 7, 2025 10:30am

Alentis raises $181M series D to bring ADCs to the clinic

Nov 12, 2024 7:00am

Surrozen's Wnt mimetic antibody works in mice with lung fibrosis

Apr 4, 2024 4:30am

Ventoux drug slows fibrosis in mouse model of hand condition

Mar 12, 2024 11:00am